Milestone® Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference
Milestone Pharmaceuticals (Nasdaq: MIST) has announced its participation in the TD Cowen 45th Annual Health Care Conference in Boston, scheduled for March 3-5, 2025. President and CEO Joe Oliveto will lead a fireside chat presentation on March 4th at 9:10 AM EST.
The presentation will be accessible through a live webcast for conference attendees, with a replay option available for approximately 90 days afterward on the company's website in the News & Events section at www.milestonepharma.com. Interested parties seeking meetings with the Milestone team during the conference should contact their TD Cowen representative.
Milestone Pharmaceuticals (Nasdaq: MIST) ha annunciato la sua partecipazione alla 45ª Conferenza Annuale sulla Salute di TD Cowen a Boston, in programma dal 3 al 5 marzo 2025. Il Presidente e CEO Joe Oliveto condurrà una presentazione a chiacchierata informale il 4 marzo alle 9:10 AM EST.
La presentazione sarà accessibile tramite una diretta web per i partecipanti alla conferenza, con un'opzione di riproduzione disponibile per circa 90 giorni successivi sul sito web dell'azienda nella sezione News & Events su www.milestonepharma.com. Le parti interessate che desiderano incontrare il team di Milestone durante la conferenza possono contattare il loro rappresentante di TD Cowen.
Milestone Pharmaceuticals (Nasdaq: MIST) ha anunciado su participación en la 45ª Conferencia Anual de Salud de TD Cowen en Boston, programada del 3 al 5 de marzo de 2025. El Presidente y CEO Joe Oliveto liderará una presentación de charla informal el 4 de marzo a las 9:10 AM EST.
La presentación estará disponible a través de una transmisión en vivo para los asistentes a la conferencia, con una opción de repetición disponible durante aproximadamente 90 días después en el sitio web de la empresa en la sección de Noticias y Eventos en www.milestonepharma.com. Las partes interesadas que deseen reunirse con el equipo de Milestone durante la conferencia deben contactar a su representante de TD Cowen.
Milestone Pharmaceuticals (Nasdaq: MIST)는 2025년 3월 3일부터 5일까지 보스턴에서 열리는 TD Cowen 제45회 연례 건강 관리 컨퍼런스에 참여한다고 발표했습니다. 사장 겸 CEO인 Joe Oliveto가 3월 4일 오전 9시 10분 EST에 파이어사이드 채팅 프레젠테이션을 이끌 것입니다.
프레젠테이션은 컨퍼런스 참석자를 위한 라이브 웹캐스트를 통해 접근 가능하며, 이후 약 90일 동안 회사 웹사이트의 뉴스 및 이벤트 섹션(www.milestonepharma.com)에서 다시 볼 수 있는 옵션이 제공됩니다. 컨퍼런스 중 Milestone 팀과 회의를 원하는 관련자는 TD Cowen 대표에게 연락해야 합니다.
Milestone Pharmaceuticals (Nasdaq: MIST) a annoncé sa participation à la 45ème Conférence Annuelle sur la Santé de TD Cowen à Boston, prévue du 3 au 5 mars 2025. Le Président et CEO Joe Oliveto dirigera une présentation de type 'fireside chat' le 4 mars à 9h10 EST.
La présentation sera accessible via un webinaire en direct pour les participants à la conférence, avec une option de rediffusion disponible pendant environ 90 jours par la suite sur le site web de l'entreprise dans la section Actualités et Événements à www.milestonepharma.com. Les parties intéressées souhaitant rencontrer l'équipe de Milestone durant la conférence doivent contacter leur représentant de TD Cowen.
Milestone Pharmaceuticals (Nasdaq: MIST) hat seine Teilnahme an der 45. jährlichen Gesundheitskonferenz von TD Cowen in Boston angekündigt, die vom 3. bis 5. März 2025 stattfinden wird. Präsident und CEO Joe Oliveto wird am 4. März um 9:10 Uhr EST eine informelle Gesprächspräsentation leiten.
Die Präsentation wird für die Konferenzteilnehmer über einen Live-Webcast zugänglich sein, mit einer Wiederholungsoption, die etwa 90 Tage lang auf der Unternehmenswebsite im Bereich Nachrichten & Veranstaltungen unter www.milestonepharma.com verfügbar ist. Interessierte, die während der Konferenz Meetings mit dem Milestone-Team anstreben, sollten ihren TD Cowen-Vertreter kontaktieren.
- None.
- None.
MONTREAL and CHARLOTTE, N.C., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that President and CEO, Joe Oliveto, will present at the TD Cowen 45th Annual Health Care Conference, to take place from March 3-5, 2025 in Boston.
A live webcast of the fireside chat will be available to conference participants on March 4th at 9:10 AM EST. The webcast is available to watch both live and replay for approximately 90-days following the presentation in the News & Events section of Milestone's website www.milestonepharma.com. If you are interested in meeting with the Milestone team during the conference, please reach out to your TD Cowen representative.
About Milestone Pharmaceuticals
Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a biopharmaceutical company developing and commercializing innovative cardiovascular solutions to improve the lives of people living with complex and life-altering heart conditions. The Company’s focus on understanding unmet patient needs and improving the patient experience has led us to develop new treatment approaches that provide patients with an active role in self-managing their care. Milestone's lead investigational product is etripamil, a novel calcium channel blocker nasal spray that is being studied for patients to self-administer without medical supervision to treat symptomatic episodic attacks associated with PSVT and AFib-RVR.
Contact:
Kim Fox, Vice President, Communications, kfox@milestonepharma.com
Investor Relations
Chris Calabrese, ccalabrese@lifesciadvisors.com
Kevin Gardner, kgardner@lifesciadvisors.com
FAQ
When is Milestone Pharmaceuticals (MIST) presenting at the TD Cowen Healthcare Conference 2025?
How can investors access Milestone Pharmaceuticals' (MIST) TD Cowen conference presentation?
Who will represent Milestone Pharmaceuticals (MIST) at the 2025 TD Cowen Healthcare Conference?
How long will the replay of MIST's TD Cowen conference presentation be available?
